Senior insider sale
Chief Financial Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$406.6K
33.12K shares
What this filing means
WENTWORTH KORY JAMES plans to sell 33.12K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $406.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001950047-26-002377
Officer· Chief Financial Officer
Since Oct 2021
33.12K
Shares to sell
$406.6K
Approx. market value
16.48K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
9/1/2025
7.08KPreviously Exercised Stock Options
Cash
6/29/2023
9.39KTotal acquired16.48K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2025 | Restricted Stock Units N/A | 7.08K | — |
6/29/2023 | Previously Exercised Stock Options Cash | 9.39K | — |
| Total | 16.48K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
7.99K
Market value
$97.9K
3/4/2026
—Completed
Units to sell
5.71K
Market value
$67.2K
3/3/2026
—Completed
Units to sell
2.94K
Market value
$34.3K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.48K
Market value
$207.3K
3/9/2026
Total
Units
33.12K
Value
$406.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 7.99K | $97.9K | — | Completed |
3/3/2026 | 5.71K | $67.2K | — | Completed |
3/2/2026 | 2.94K | $34.3K | — | Completed |
| Planned — Approximate Date | ||||
3/9/2026 | 16.48K | $207.3K | NASDAQ | Planned |
| Total | 33.12K | $406.6K | ||